People'S Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit 29.52%
(FY 2023)
- Ebitda -44.13%
(FY 2023)
- Net Worth -0.24%
(FY 2023)
- Total Assets -5.68%
(FY 2023)
About People'S Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Savitri Vijay and Ambrish Sharma serve as directors at the Company.
- CIN/LLPIN
U24230MP2010PTC023140
- Company No.
023140
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Mar 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at People'S Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Savitri Vijay  | Director | 11-Nov-2017 | Current |
| Ambrish Sharma | Director | 20-Jul-2016 | Current |
Financial Performance of People'S Pharmaceuticals.
People'S Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 29.52% increase in profit. The company's net worth dipped by a decrease of 0.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of People'S Pharmaceuticals?
In 2023, People'S Pharmaceuticals had a promoter holding of 99.90% and a public holding of 0.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Explore Natural Resources Services & Supplies Private LimitedActive 16 years 7 monthsSavitri Vijay and Ambrish Sharma are mutual person
- Aanya Cine & Media Ventures Private LimitedActive 14 years 6 months
Savitri Vijay and Ambrish Sharma are mutual person
- Livett International Private LimitedActive 8 years 5 months
Savitri Vijay and Ambrish Sharma are mutual person
- Peoples Art Culture And Education Foundation BhopalActive 11 years 4 months
Savitri Vijay and Ambrish Sharma are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at People'S Pharmaceuticals?
Unlock and access historical data on people associated with People'S Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of People'S Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped People'S Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
